Press Releases

Targeted Therapeutics Market is Anticipated to Grow US$ 80 Bn By 2027

Share This Article

[150+ Pages Research Report] According to the recent analysis research report; the global Targeted Therapeutics Market in 2020 was approximately USD 67.9 Billion. The market is expected to grow at a CAGR of 1.6% and is anticipated to reach around USD  80 Billion by 2027. Top market players are. Amgen, Inc., F. Hoffmann-La Roche Ltd., AstraZeneca, Bristol-Myers Squibb Company, Bayer AG, Merck & Co., Inc., Novartis AG, and Pfizer, Inc. In

Get your Customized Research Report@https://www.novaoneadvisor.com/report/customization/5696

Report Scope of the Targeted Therapeutics Market

Report Scope Details
Market Size USD 80 Billion by 2027
Growth Rate CAGR of 1.6% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Historic Data 2017 to 2020
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Type, Application, Distribution Channel and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Amgen, Inc., F. Hoffmann-La Roche Ltd., AstraZeneca, Bristol-Myers Squibb Company, Bayer AG, Merck & Co., Inc., Novartis AG, and Pfizer, Inc. In

Growth Factors:

Targeted therapies are drugs or other substances that block the growth of unwanted cells and pathogens by interfering with specific molecules (“molecular targets”) involved in the growth, progression, and spread of disease. Targeted therapies are sometimes called molecularly targeted drugs, molecularly targeted therapies, precision medicines, etc. The emerging field of target therapeutics offers varied potential treatments. Targeted therapies offer the possibility of finding a cure for diseases with significant unmet needs, including orphan diseases and diseases having a high burden globally. Targeted therapy is widely used in the treatment of different forms of cancer such as renal, breast, lung, colorectal, and leukemia, and other diseases such as multiple sclerosis and wet age-related macular degeneration. The global targeted therapeutics market is driven by rise in prevalence of cancer across the globe, increase in global geriatric population, and surge in product approvals.

North America dominated the global targeted therapeutics market in 2020, followed by Europe, and the trend is anticipated to continue during the forecast period. North America’s dominance can be ascribed to high prevalence and increase in incidence rates of cancer, well-established healthcare industry, and rise in adoption of targeted therapeutics monoclonal antibodies in the region.

COVID-19 Impact on Targeted Therapeutics Sales

  • Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Targeted Therapeutics market.
  • Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.
  • Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.
  • Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Targeted Therapeutics market 2021 onwards. This trend will however continue through the course of the report’s assessment period

Targeted Therapeutics Market: Prominent Regions

In terms of region, the global targeted therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global targeted therapeutics market in 2020, followed by Europe. The U.S. dominated the targeted therapeutics market in North America in 2020, due to the presence of key players, adoption of targeted therapeutics monoclonal antibodies, and adequate reimbursement policies. This, in turn, is expected to boost the market in the region. The targeted therapeutics market in Asia Pacific is likely to expand at a high CAGR from 2021 to 2027. The growth of the market in the region can be attributed to the adoption of new targeted therapeutic drugs, increase in awareness about various oncological disorders, rise in healthcare expenditure, and high penetration of research activities across the region.

Download This Full Research Report (Single User License US$ 3500)@https://www.novaoneadvisor.com/report/checkout/5696

Recent report on the Targeted Therapeutics market, with the help of a comprehensive outlook, provides readers with an assessment of the global market landscape. This study on the Targeted Therapeutics market analyzes the scenario for the period of 2017 to 2027, wherein, 2021 is the base year and 2020 is historical data. This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global Targeted Therapeutics market for the forecast period of 2021–2027. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.

The report analyzes the historical and present-day scenario of the global Targeted Therapeutics market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the Targeted Therapeutics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the market.

The report delves into the competition landscape of the global Targeted Therapeutics market. Key players operating in the market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the Targeted Therapeutics market that are profiled in this report.

Y-o-Y growth comparison, volume and revenue comparison, and market share comparison of various market segments are provided in the report. The Targeted Therapeutics market is analyzed at both regional and country levels.

Key Players:

This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Targeted Therapeutics market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.

Some of the prominent players in the Targeted Therapeutics market include:

Amgen, Inc., F. Hoffmann-La Roche Ltd., AstraZeneca, Bristol-Myers Squibb Company, Bayer AG, Merck & Co., Inc., Novartis AG, and Pfizer, Inc. In
Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Global Targeted Therapeutics Market: Segmentation

  • Targeted Therapeutics Market, by Type
    • Monoclonal Antibodies
      • Angiogenesis Inhibitors
      • HER-2 Targeted Agents
      • Anti-CD20 Monoclonal Antibodies
    • Small Molecule
      • Tyrosine Kinase Inhibitors
      • mTOR Inhibitors
      • PARP Inhibitors
  • Targeted Therapeutics Market, by Application
    • Breast Cancer
    • Colorectal Cancer
    • Leukemia
    • Lung Cancer
    • Lymphoma
    • Multiple Sclerosis
    • Renal Cancer
    • Wet Age-related Macular Degeneration
    • Others (Ovarian Cancer, Fallopian Tube Cancer, Prostate Cancer, and Pancreatic Cancer)
  • Targeted Therapeutics Market, by Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

 Research Methodology

A unique research methodology has been utilized to conduct a comprehensive research on the growth of the global Targeted Therapeutics market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.

These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global Targeted Therapeutics market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.

Key Questions are

  • What are the key factors influencing the Targeted Therapeutics market in each region?
  • How much value will the global market generate by the end of the forecast period?
  • What will be the CAGR of the global market between 2021 and 2027?
  • What would be the Y-o-Y growth trend of the global market between 2021 and 2027?
  • What is the future scope and current trends in technologies of the global market?
  • What is the revenue of the global market based on segments?
  • Which key strategies are used by top players of the global market?
  • Which are the leading companies in the global market?
  • What are the essential strategies by key stakeholders in the market to expand their geographic presence?
  • What are the major advancements witnessed in the global market?

Why should you invest in this report?

If you are aiming to enter the global Targeted Therapeutics market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for Targeted Therapeutics are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2027 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Targeted Therapeutics Market, By Type

7.1.  Targeted Therapeutics Market, by Type, 2021-2027

7.1.1.     Monoclonal Antibodies

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Small Molecule

7.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Targeted Therapeutics Market, By Application

8.1.  Targeted Therapeutics Market, by Application, 2021-2027

8.1.1.     Breast Cancer

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Colorectal Cancer

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Leukemia

8.1.3.1.          Market Revenue and Forecast (2016-2027)

8.1.4.     Lung Cancer

8.1.4.1.          Market Revenue and Forecast (2016-2027)

8.1.5.     Lymphoma

8.1.5.1.          Market Revenue and Forecast (2016-2027)

8.1.6.     Multiple Sclerosis

8.1.6.1.          Market Revenue and Forecast (2016-2027)

8.1.7.     Renal Cancer

8.1.7.1.          Market Revenue and Forecast (2016-2027)

8.1.8.     Wet Age-related Macular Degeneration

8.1.8.1.          Market Revenue and Forecast (2016-2027)

8.1.9.     Others

8.1.9.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Targeted Therapeutics Market, By Distribution Channel

9.1.  Targeted Therapeutics Market, by Distribution Channel, 2021-2027

9.1.1.     Hospital Pharmacies

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Retail Pharmacies

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Online Pharmacies

9.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Targeted Therapeutics  Market, Regional Estimates and Trend Forecast

10.1.          North America

10.1.1.  Market Revenue and Forecast, by Type (2016-2027)

10.1.2.  Market Revenue and Forecast, by Application (2016-2027)

10.1.3.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.1.4.  U.S.

10.1.4.1.       Market Revenue and Forecast, by Type (2016-2027)

10.1.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.1.4.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.1.5.  Rest of North America

10.1.5.1.       Market Revenue and Forecast, by Type (2016-2027)

10.1.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.1.5.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2.          Europe

10.2.1.  Market Revenue and Forecast, by Type (2016-2027)

10.2.2.  Market Revenue and Forecast, by Application (2016-2027)

10.2.3.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2.4.  UK

10.2.4.1.       Market Revenue and Forecast, by Type (2016-2027)

10.2.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.2.4.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2.5.  Germany

10.2.5.1.       Market Revenue and Forecast, by Type (2016-2027)

10.2.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.2.5.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2.6.  France

10.2.6.1.       Market Revenue and Forecast, by Type (2016-2027)

10.2.6.2.       Market Revenue and Forecast, by Application (2016-2027)

10.2.6.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.2.7.  Rest of Europe

10.2.7.1.       Market Revenue and Forecast, by Type (2016-2027)

10.2.7.2.       Market Revenue and Forecast, by Application (2016-2027)

10.2.7.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3.          APAC

10.3.1.  Market Revenue and Forecast, by Type (2016-2027)

10.3.2.  Market Revenue and Forecast, by Application (2016-2027)

10.3.3.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3.4.  India

10.3.4.1.       Market Revenue and Forecast, by Type (2016-2027)

10.3.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.3.4.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3.5.  China

10.3.5.1.       Market Revenue and Forecast, by Type (2016-2027)

10.3.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.3.5.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3.6.  Japan

10.3.6.1.       Market Revenue and Forecast, by Type (2016-2027)

10.3.6.2.       Market Revenue and Forecast, by Application (2016-2027)

10.3.6.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.3.7.  Rest of APAC

10.3.7.1.       Market Revenue and Forecast, by Type (2016-2027)

10.3.7.2.       Market Revenue and Forecast, by Application (2016-2027)

10.3.7.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4.          MEA

10.4.1.  Market Revenue and Forecast, by Type (2016-2027)

10.4.2.  Market Revenue and Forecast, by Application (2016-2027)

10.4.3.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4.4.  GCC

10.4.4.1.       Market Revenue and Forecast, by Type (2016-2027)

10.4.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.4.4.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4.5.  North Africa

10.4.5.1.       Market Revenue and Forecast, by Type (2016-2027)

10.4.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.4.5.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4.6.  South Africa

10.4.6.1.       Market Revenue and Forecast, by Type (2016-2027)

10.4.6.2.       Market Revenue and Forecast, by Application (2016-2027)

10.4.6.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.4.7.  Rest of MEA

10.4.7.1.       Market Revenue and Forecast, by Type (2016-2027)

10.4.7.2.       Market Revenue and Forecast, by Application (2016-2027)

10.4.7.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.5.          Latin America

10.5.1.  Market Revenue and Forecast, by Type (2016-2027)

10.5.2.  Market Revenue and Forecast, by Application (2016-2027)

10.5.3.  Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.5.4.  Brazil

10.5.4.1.       Market Revenue and Forecast, by Type (2016-2027)

10.5.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.5.4.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

10.5.5.  Rest of LATAM

10.5.5.1.       Market Revenue and Forecast, by Type (2016-2027)

10.5.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.5.5.3.       Market Revenue and Forecast, by Distribution Channel (2016-2027)

Chapter 11.   Company Profiles

11.1.                 Amgen, Inc.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.                 F. Hoffmann-La Roche Ltd.

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.                 AstraZeneca

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.                 Bristol-Myers Squibb Company

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.                 Bayer AG

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.                 Bayer AG

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.                 Novartis AG

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.                 Pfizer, Inc. In

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

Chapter 12.   Research Methodology

12.1.                 Primary Research

12.2.                 Secondary Research

12.3.                 Assumptions

Chapter 13.   Appendix

13.1.                 About Us

13.2.                 Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Purchase Full Research Report (Single User License US$ 3500)@https://www.novaoneadvisor.com/report/checkout/5696

About Us

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@novaoneadvisor.com

Show More

Steve Robber

My name is Steve Robber, I’m the Owner of Market Stats News. Steve has served in many positions at various organizations for the past seven years. Currently he is an Author at Finance.Yahoo. Contact us for a free news publication, we look forward to speaking with you!

Related Articles

Back to top button